Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2014 (2014), Article ID 479641, 5 pages
http://dx.doi.org/10.1155/2014/479641
Case Report

Three-Year Successful Cinacalcet Treatment of Secondary Hyperparathyroidism in a Patient with X-Linked Dominant Hypophosphatemic Rickets: A Case Report

Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Tage-Hansens Gade, 8000 Aarhus C, Denmark

Received 9 December 2013; Accepted 3 January 2014; Published 10 February 2014

Academic Editors: M. A. Boyanov and W. V. Moore

Copyright © 2014 Diana Grove-Laugesen and Lars Rejnmark. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Albright, A. M. Butler, and E. Bloomberg, “Rickets resistant to vitamin D therapy,” American Journal of Diseases of Children, vol. 54, pp. 529–547, 1937. View at Google Scholar
  2. G. I. Baroncelli, M. Angiolini, E. Ninni, V. Galli, R. Saggese, and M. R. Giuca, “Prevalence and pathogenesis of dental and periodontal lesions in children with X-linked hypophosphatemic rickets,” European Journal of Paediatric Dentistry, vol. 7, no. 2, pp. 61–66, 2006. View at Google Scholar · View at Scopus
  3. I. R. Reid, D. C. Hardy, W. A. Murphy, S. L. Teitelbaum, M. A. Bergfeld, and M. P. Whyte, “X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults,” Medicine, vol. 68, no. 6, pp. 336–352, 1989. View at Google Scholar · View at Scopus
  4. J. Q. Feng, E. L. Clinkenbeard, B. Yuan, K. E. White, and M. K. Drezner, “Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia,” Bone, vol. 54, no. 2, pp. 213–221, 2013. View at Publisher · View at Google Scholar
  5. F. Francis, S. Hennig, B. Korn et al., “A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets,” Nature Genetics, vol. 11, no. 2, pp. 130–136, 1995. View at Google Scholar · View at Scopus
  6. G. I. Baroncelli, S. Bertelloni, F. Sodini et al., “Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets,” Pediatric Endocrinology Reviews, vol. 1, no. 4, pp. 361–379, 2004. View at Google Scholar · View at Scopus
  7. E. A. Imel, L. A. DiMeglio, S. L. Hui, T. O. Carpenter, and M. J. Econs, “Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1846–1850, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. P. Krohn, G. Offermann, M. Brandis, J. Brodehl, K. Hanke, and G. Offner, “Occurrence of hyperparathyroidism in children with X-linked hypophosphatemia under treatment with vitamin D and phsophate,” Advances in Experimental Medicine and Biology, vol. 81, pp. 345–351, 1977. View at Google Scholar · View at Scopus
  9. H. Ræder, N. Shaw, C. Netelenbos, and R. Bjerknes, “A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet,” European Journal of Endocrinology, vol. 159, no. 1, pp. S101–S105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. U. S. Alon, R. Monzavi, M. Lilien, M. Rasoulpour, M. E. Geffner, and O. Yadin, “Hypertension in hypophosphatemic rickets—role of secondary hyperparathyroidism,” Pediatric Nephrology, vol. 18, no. 2, pp. 155–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. L. G. Hammerland, J. E. Garrett, B. C. P. Hung, C. Levinthal, and E. F. Nemeth, “Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568,” Molecular Pharmacology, vol. 53, no. 6, pp. 1083–1088, 1998. View at Google Scholar · View at Scopus
  12. E. F. Nemeth, M. E. Steffey, L. G. Hammerland et al., “Calcimimetics with potent and selective activity on the parathyroid calcium receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 4040–4045, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. G. A. Block, K. J. Martin, A. L. M. de Francisco et al., “Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis,” The New England Journal of Medicine, vol. 350, no. 15, pp. 1516–1525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. U. S. Alon, R. Levy-Olomucki, W. V. Moore, J. Stubbs, S. Liu, and L. D. Quarles, “Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 3, pp. 658–664, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Peacock, M. A. Bolognese, M. Borofsky et al., “Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 4860–4867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. Yavropoulou, K. Kotsa, A. G. Psarrakou et al., “Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review,” Hormones, vol. 9, no. 3, pp. 274–278, 2010. View at Google Scholar · View at Scopus
  17. J. L. Geller, A. Khosravi, M. H. Kelly, M. Riminucci, J. S. Adams, and M. T. Collins, “Clinical vignette: cinacalcet in the management of tumor-induced osteomalacia,” Journal of Bone and Mineral Research, vol. 22, no. 6, pp. 931–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Belozeroff, W. G. Goodman, L. Ren, and K. Kalantar-Zadeh, “Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 3, pp. 673–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Dvorak, A. Siddiqua, D. T. Ward et al., “Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 5140–5145, 2004. View at Publisher · View at Google Scholar · View at Scopus